porcine circovirus type 2 orf2 subunit antigen
intervet australia pty limited - porcine circovirus type 2 orf2 subunit antigen - unknown - porcine circovirus type 2 orf2 subunit antigen vaccine-viral active 0.0 - active constituent
porcilis pcv m hyo
intervet international b.v. - porcine circovirus type 2 (pcv2) orf2 subunit antigen, mycoplasma hyopneumoniae j strain inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs (for fattening) - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (pcv2) infection, and severity of lung lesions caused by mycoplasma hyopneumoniae infection. to reduce the loss of daily weight gain during the finishing period in face of infections with mycoplasma hyopneumoniae and/or pcv2 (as observed in field studies)
porcilis pcv
intervet international bv - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae - pigs - for the active immunisation of pigs to reduce the virus load in blood and lymphoid tissues and to reduce weight loss associated with porcine-circovirus-type-2 infection occurring during the fattening period.onset of immunity: 2 weeksduration of immunity: 22 weeks
porcilis pcv vaccine
intervet australia pty limited - porcine circovirus type 2 orf2 subunit antigen - misc. vaccines or anti sera - porcine circovirus type 2 orf2 subunit antigen vaccine-viral active 2.0 mg/2ml - immunotherapy
porcilis pcv formulation: each 2 ml (dose) contains: porcine circovirus (pcv) type 2 orf2 subunit antigen........ > 3720 au au-antigenic units emulsion for injection (im)
msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - inactivated porcine circovirus (pcv) vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: porcine circovirus (pcv) type 2 orf2 subunit antigen........ > 3720 au au-antigenic units
porcilis pcv id
intervet international b.v. - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae, inactivated viral vaccines - pigs - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection. to reduce loss of daily weight gain and mortality associated with pcv2 infection.
porcilis pcv m hyo
intervet australia pty limited - porcine circovirus type 2 orf2 subunit antigen; mycoplasma hyopneumoniae - inactivated antigen - vaccine or antisera - porcine circovirus type 2 orf2 subunit antigen vaccine-viral active 1414.0 au/ml; mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 2.69 rp - immunotherapy
ingelvac circoflex suspension for injection in pigs
boehringer ingelheim animal health australia pty. ltd. - porcine circovirus type 2 orf2 protein; carbomer - misc. vaccines or anti sera - porcine circovirus type 2 orf2 protein vaccine-viral active 1.0 ml/do; carbomer ungrouped other 1.0 mg - immunotherapy - pigs - see label for type - disease control
porcine circovirus type 2 orf2 protein
boehringer ingelheim animal health australia pty. ltd. - porcine circovirus type 2 orf2 protein - unknown - porcine circovirus type 2 orf2 protein vaccine-viral active 0.0 - active constituent
porcilis pcv idal emulsion for injection for pigs
intervet australia pty limited - porcine circovirus type 2 orf2 subunit antigen - misc. vaccines or anti sera - porcine circovirus type 2 orf2 subunit antigen vaccine-viral active 7180.0 au/ml - immunotherapy